These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9746266)

  • 1. Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses.
    Laplaud PM; Dantoine T; Chapman MJ
    Clin Chem Lab Med; 1998 Jun; 36(7):431-41. PubMed ID: 9746266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
    J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
    Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.
    Pasdar A; Ross-Adams H; Cumming A; Cheung J; Whalley L; St Clair D; MacLeod MJ
    BMC Med Genet; 2006 Mar; 7():28. PubMed ID: 16551349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase and atherosclerosis-related cardiovascular diseases.
    Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
    Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: The role of paraoxonase in cardiovascular diseases.
    Kowalska K; Socha E; Milnerowicz H
    Ann Clin Lab Sci; 2015; 45(2):226-33. PubMed ID: 25887882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does paraoxonase play a role in susceptibility to cardiovascular disease?
    Aviram M
    Mol Med Today; 1999 Sep; 5(9):381-6. PubMed ID: 10462749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
    Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
    Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
    Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The three-gene paraoxonase family: physiologic roles, actions and regulation.
    Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E
    Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection.
    Khalil A; Fulop T; Berrougui H
    Antioxid Redox Signal; 2021 Jan; 34(3):191-200. PubMed ID: 31969002
    [No Abstract]   [Full Text] [Related]  

  • 17. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of paraoxonases: a brief review.
    Draganov DI; La Du BN
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
    Draganov DI; Stetson PL; Watson CE; Billecke SS; La Du BN
    J Biol Chem; 2000 Oct; 275(43):33435-42. PubMed ID: 10931838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.